{"id":"W2591397831","doi":"10.1200/jco.2016.34.2_suppl.499","title":"Subgroup analyses of METEOR, a randomized phase 3 trial of cabozantinib versus everolimus in patients (pts) with advanced renal cell carcinoma (RCC).","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Cabozantinib; Medicine; Clinical endpoint; Everolimus; Internal medicine; Interim analysis; Population; Oncology; Renal cell carcinoma; Randomized controlled trial; Pazopanib; Progression-free survival; Sunitinib; Urology; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00677564,0.001548201,0.003651912,0.0008221223,0.0003303249,0.0009379895,0.0007840337,0.001284583,0.005340447],"category_scores_gemma":[0.008051923,0.0004167288,0.0100149,0.0006564711,0.0003512473,0.000795391,0.0007711712,0.001682073,0.0003684298],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007630559,"about_ca_system_score_gemma":0.001143257,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008415655,"about_ca_topic_score_gemma":0.002869896,"domain_scores_codex":[0.9967639,0.001820413,0.0004392045,0.0004318952,0.0002657322,0.0002788514],"domain_scores_gemma":[0.9974624,0.001268972,0.0006119971,0.0003181689,0.0001156562,0.00022274],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9240357,0.0004724747,0.009362042,0.00184286,0.04123167,0.0002086756,0.00008442092,0.001053397,0.002164221,0.0001969217,0.002011315,0.01733634],"study_design_scores_gemma":[0.6980531,0.0681195,0.07839186,0.0003818543,0.13339,0.0005825005,0.0002975038,0.007038141,0.002566691,0.003057293,0.007954745,0.0001667899],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9580595,0.02242486,0.002733366,0.001007182,0.0009323449,0.003492791,0.008124506,0.0002175538,0.003007895],"genre_scores_gemma":[0.9884116,0.001588643,0.001626615,0.0007141507,0.0002995729,0.002645066,0.003344485,0.00004105352,0.001328774],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00677564,"threshold_uncertainty_score":0.03583348,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1315458246489042,"score_gpt":0.4595782746031576,"score_spread":0.3280324499542533,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}